About us

ASCT specializes in the manufacture and conversion services of peripheral blood into Autologous Multi-Lineage Potential Cells (AMPC) through our proprietary technology.

Our proprietary technology enables a swift turnaround time; between 3~4 day, peripheral blood can be converted into AMPC.  This entire conversion process is conducted within a closed system environment and does not utilize any animal components, cell expansion techniques or genetic engineering.